We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc

Delisted

ARNA was delisted on the 10th of March, 2022.

121 hedge funds and large institutions have $451M invested in Arena Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 129121 (-8)

13% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 39

28% less capital invested

Capital invested by funds: $628M → $451M (-$177M)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

50% less call options, than puts

Call options by funds: $12.7M | Put options by funds: $25.4M

Holders
121
Holders Change
-8
Holders Change %
-6.2%
% of All Funds
3.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
34
Reduced
39
Closed
21
Calls
$12.7M
Puts
$25.4M
Net Calls
-$12.6M
Net Calls Change
+$7.61M
Name Holding Trade Value Shares
Change
Change in
Stake
Canada Pension Plan Investment Board
26
Canada Pension Plan Investment Board
Ontario, Canada
$1.76M +$1.46M +32,660 +350%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$1.7M +$20.1K +450 +1%
QBFM
28
QS Batterymarch Financial Management
New York
$1.42M -$198K -4,435 -12%
CS
29
Credit Suisse
Switzerland
$1.26M -$1.82M -40,671 -58%
GH
30
GAM Holding
Switzerland
$1.25M +$317K +7,096 +31%
USAA
31
United Services Automobile Association
Texas
$1.19M +$332K +7,440 +35%
Cambridge Investment Research Advisors
32
Cambridge Investment Research Advisors
Iowa
$1.12M +$897K +20,085 +299%
Morgan Stanley
33
Morgan Stanley
New York
$1.1M -$9.76M -218,642 -89%
Swiss National Bank
34
Swiss National Bank
Switzerland
$1M -$18.3K -410 -2%
Allianz Asset Management
35
Allianz Asset Management
Germany
$973K
CA
36
Commerzbank Aktiengesellschaft
Germany
$954K -$618K -13,833 -38%
MP
37
Mangrove Partners
Connecticut
$884K +$942K +21,090 New
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$855K -$446 -10 -0%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$851K -$1.34M -29,981 -60%
ProShare Advisors
40
ProShare Advisors
Maryland
$840K -$216K -4,833 -19%
State Board of Administration of Florida Retirement System
41
State Board of Administration of Florida Retirement System
Florida
$834K
American Century Companies
42
American Century Companies
Missouri
$810K +$63.4K +1,419 +8%
Goldman Sachs
43
Goldman Sachs
New York
$799K -$2.76M -61,916 -76%
MLICM
44
Metropolitan Life Insurance Company (MetLife)
New York
$751K
VFA
45
Virtus Fund Advisers
Connecticut
$713K -$78.4K -1,755 -9%
NFA
46
Nationwide Fund Advisors
Ohio
$709K +$179 +4 +0%
Barclays
47
Barclays
United Kingdom
$674K +$533K +11,941 +244%
VOYA Investment Management
48
VOYA Investment Management
Georgia
$577K
Citadel Advisors
49
Citadel Advisors
Florida
$550K +$160K +3,592 +38%
ARTA
50
A.R.T. Advisors
New York
$541K +$575K +12,889 New

ARNA Hedge Fund Activity: Q3 2014 in Review

121 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2014, worth a combined $451M — down 28% from $628M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ARNA and 14 opened new positions — a net loss of 7 holders — while 39 trimmed existing stakes and 34 added.

The largest buyer was Wellington Management Group, adding an estimated $7.74M. The largest seller was Morgan Stanley, cutting an estimated $9.76M.

  • 121 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2014, down from 129 in Q2 2014.
  • Funds reported $451M of Arena Pharmaceuticals Inc stock for Q3 2014, down 28% quarter-over-quarter.
  • 14 funds opened new Arena Pharmaceuticals Inc positions in Q3 2014 and 21 closed out, a net change of -7 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2014 was Wellington Management Group, an estimated $7.74M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2014 was Morgan Stanley, an estimated $9.76M sold.

Based on aggregated 13F filings for Q3 2014.